Use of VISIUS iCT does not require patient transport or need for floor-mounted rails like other CT systems which opens up valuable OR space and provides unimpeded movement of surgical equipment. The surgical team can maintain familiar surgical protocols, workflow and infection control procedures. Portable CT systems on the market deliver lesser image quality. The VISIUS iCT also offers the longest scanner travel range on the market today.
Minimizing radiation dose is critical. VISIUS iCT features a suite of software applications such as 3D volume rendering to aid in surgical planning and dose reduction algorithms which consider a patient's unique characteristics and imaging target to maximize image quality and minimize dose. The system software also offers state-of-the art dose tools like iterative reconstruction and real-time dose (kV and mAs) modulation.
About IMRIS IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. The multi-room suites incorporate diagnostic quality high-field MR, CT and angio modalities accessed effortlessly in the operating room setting. VISIUS Surgical Theatres serve the neurosurgical, spinal, cardiovascular and cerebrovascular markets and have been selected by 57 leading medical institutions around the world.
SOURCE IMRIS Inc.Image with caption: "With recent TGA clearance, the IMRIS VISIUS iCT - the first and only ceiling-mounted intraoperative CT with low dose management - is available for sale in Australia. (CNW Group/IMRIS Inc.)". Image available at: http://photos.newswire.ca/images/download/20140226_C7403_PHOTO_EN_37140.jpg
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts